vs
Side-by-side financial comparison of Dianthus Therapeutics, Inc. (DNTH) and Onconetix, Inc. (ONCO). Click either name above to swap in a different company.
Onconetix, Inc. is the larger business by last-quarter revenue ($303.6K vs $284.0K, roughly 1.1× Dianthus Therapeutics, Inc.). Onconetix, Inc. runs the higher net margin — 1867.5% vs -22687.3%, a 24554.8% gap on every dollar of revenue. On growth, Onconetix, Inc. posted the faster year-over-year revenue change (-57.4% vs -78.6%). Over the past eight quarters, Onconetix, Inc.'s revenue compounded faster (-34.2% CAGR vs -44.6%).
Dianthus Therapeutics is a clinical-stage biopharmaceutical firm focused on developing targeted therapies for rare immunological and inflammatory diseases. It advances antibody-based candidates to address unmet needs of severe patients, operating primarily in the U.S. with global development partners.
Onconetix, Inc. is a clinical-stage biopharmaceutical firm developing innovative targeted therapies for underserved cancer patients. Its pipeline includes candidates for hard-to-treat solid tumors, operating mainly across North American and global oncology markets, prioritizing treatments with superior safety and efficacy over existing standard care options.
DNTH vs ONCO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0K | $303.6K |
| Net Profit | $-64.4M | $5.7M |
| Gross Margin | — | 81.6% |
| Operating Margin | -24486.3% | -422.1% |
| Net Margin | -22687.3% | 1867.5% |
| Revenue YoY | -78.6% | -57.4% |
| Net Profit YoY | -126.6% | 119.3% |
| EPS (diluted) | $-1.53 | $-5.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0K | $303.6K | ||
| Q3 25 | $396.0K | $303.7K | ||
| Q2 25 | — | $106.5K | ||
| Q1 25 | $1.2M | $101.6K | ||
| Q4 24 | $1.3M | $712.0K | ||
| Q3 24 | $2.2M | $406.9K | ||
| Q2 24 | $1.9M | $704.8K | ||
| Q1 24 | $874.0K | $700.4K |
| Q4 25 | $-64.4M | $5.7M | ||
| Q3 25 | $-36.8M | $-8.8M | ||
| Q2 25 | — | $-2.4M | ||
| Q1 25 | $-29.5M | $-8.5M | ||
| Q4 24 | $-28.4M | $-29.4M | ||
| Q3 24 | $-25.2M | $-3.8M | ||
| Q2 24 | $-17.6M | $-14.3M | ||
| Q1 24 | $-13.7M | $-11.1M |
| Q4 25 | — | 81.6% | ||
| Q3 25 | — | 88.6% | ||
| Q2 25 | — | 66.2% | ||
| Q1 25 | — | 45.1% | ||
| Q4 24 | — | 92.7% | ||
| Q3 24 | — | 25.9% | ||
| Q2 24 | — | 14.3% | ||
| Q1 24 | — | 27.0% |
| Q4 25 | -24486.3% | -422.1% | ||
| Q3 25 | -10173.7% | -681.5% | ||
| Q2 25 | — | -1817.4% | ||
| Q1 25 | -2852.7% | -12369.2% | ||
| Q4 24 | -2406.9% | -4093.7% | ||
| Q3 24 | -1376.6% | -650.3% | ||
| Q2 24 | -1191.8% | -1931.6% | ||
| Q1 24 | -2041.6% | -1582.2% |
| Q4 25 | -22687.3% | 1867.5% | ||
| Q3 25 | -9284.1% | -2892.7% | ||
| Q2 25 | — | -2227.8% | ||
| Q1 25 | -2537.5% | -8408.8% | ||
| Q4 24 | -2144.8% | -4134.7% | ||
| Q3 24 | -1159.0% | -940.7% | ||
| Q2 24 | -945.1% | -2029.8% | ||
| Q1 24 | -1573.0% | -1587.4% |
| Q4 25 | $-1.53 | $-5.02 | ||
| Q3 25 | $-0.97 | $-6.25 | ||
| Q2 25 | — | $-4.76 | ||
| Q1 25 | $-0.82 | $-0.53 | ||
| Q4 24 | $-0.76 | $637.36 | ||
| Q3 24 | $-0.74 | $-249.08 | ||
| Q2 24 | $-0.51 | $-2191.59 | ||
| Q1 24 | $-0.54 | $-20.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $404.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $493.4M | $15.8M |
| Total Assets | $530.9M | $24.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $404.3M | — | ||
| Q3 25 | $402.6M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $263.2M | — | ||
| Q4 24 | $275.2M | — | ||
| Q3 24 | $281.1M | — | ||
| Q2 24 | $360.7M | — | ||
| Q1 24 | $377.0M | — |
| Q4 25 | $493.4M | $15.8M | ||
| Q3 25 | $546.5M | $3.4M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | $328.6M | $4.0M | ||
| Q4 24 | $352.5M | $8.5M | ||
| Q3 24 | $337.9M | $33.9M | ||
| Q2 24 | $358.2M | $-35.8M | ||
| Q1 24 | $372.7M | $-21.5M |
| Q4 25 | $530.9M | $24.9M | ||
| Q3 25 | $577.4M | $19.7M | ||
| Q2 25 | — | $19.1M | ||
| Q1 25 | $348.6M | $18.8M | ||
| Q4 24 | $374.0M | $28.2M | ||
| Q3 24 | $354.2M | $61.9M | ||
| Q2 24 | $369.0M | $59.5M | ||
| Q1 24 | $382.5M | $75.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-47.0M | $-3.1M |
| Free Cash FlowOCF − Capex | $-47.1M | — |
| FCF MarginFCF / Revenue | -16591.9% | — |
| Capex IntensityCapex / Revenue | 48.6% | — |
| Cash ConversionOCF / Net Profit | — | -0.55× |
| TTM Free Cash FlowTrailing 4 quarters | $-132.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-47.0M | $-3.1M | ||
| Q3 25 | $-30.6M | $-3.2M | ||
| Q2 25 | — | $-1.4M | ||
| Q1 25 | $-27.6M | $-2.0M | ||
| Q4 24 | $-27.4M | $-917.6K | ||
| Q3 24 | $-21.3M | $-1.1M | ||
| Q2 24 | $-14.5M | $-3.2M | ||
| Q1 24 | $-14.9M | $-5.2M |
| Q4 25 | $-47.1M | — | ||
| Q3 25 | $-30.6M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-27.7M | — | ||
| Q4 24 | $-27.5M | $-921.5K | ||
| Q3 24 | $-21.3M | $-1.1M | ||
| Q2 24 | $-14.5M | $-3.2M | ||
| Q1 24 | $-15.0M | $-5.2M |
| Q4 25 | -16591.9% | — | ||
| Q3 25 | -7717.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -2377.8% | — | ||
| Q4 24 | -2072.0% | -129.4% | ||
| Q3 24 | -980.3% | -282.4% | ||
| Q2 24 | -780.7% | -456.4% | ||
| Q1 24 | -1713.2% | -747.6% |
| Q4 25 | 48.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 2.3% | 0.5% | ||
| Q3 24 | 1.2% | 0.6% | ||
| Q2 24 | 0.9% | 2.5% | ||
| Q1 24 | 3.7% | 0.7% |
| Q4 25 | — | -0.55× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
